Health Catalyst Dirección
Dirección controles de criterios 3/4
El CEO de Health Catalyst es Dan Burton, nombrado en Oct 2012, tiene una permanencia de 12.08 años. posee directamente un 1.42% de las acciones de la empresa, con un valor de $6.51M. La antigüedad media del equipo directivo y de la junta directiva es de 2.2 años y 7.5 años, respectivamente.
Información clave
Dan Burton
Chief Executive Officer (CEO)
n/a
Compensación total
| Porcentaje del salario del CEO | n/a |
| Permanencia del CEO | 12.1yrs |
| Participación del CEO | 1.4% |
| Permanencia media de la dirección | 2.2yrs |
| Promedio de permanencia en la Junta Directiva | 7.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Health Catalyst: Still Optimistic On Achieving Adjusted EBITDA Targets
Sep 24Health Catalyst, Inc.'s (NASDAQ:HCAT) Shares Lagging The Industry But So Is The Business
Jul 17
Health Catalyst: Stellar Earnings Growth Projected
Jun 26Health Catalyst, Inc. (NASDAQ:HCAT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 12Benign Growth For Health Catalyst, Inc. (NASDAQ:HCAT) Underpins Its Share Price
Apr 04Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible
Mar 09Health Catalyst Looks To Slim Down As It Faces Industry Headwinds (Downgrade)
Feb 16Is Health Catalyst (NASDAQ:HCAT) A Risky Investment?
Jan 27What Health Catalyst, Inc.'s (NASDAQ:HCAT) 25% Share Price Gain Is Not Telling You
Dec 24Is Health Catalyst, Inc. (NASDAQ:HCAT) Trading At A 47% Discount?
Dec 15Is Health Catalyst (NASDAQ:HCAT) Weighed On By Its Debt Load?
Oct 24Subdued Growth No Barrier To Health Catalyst, Inc.'s (NASDAQ:HCAT) Price
Jul 31Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?
Jun 27Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?
Feb 22Health Catalyst, Inc. (NASDAQ:HCAT) Shares Could Be 22% Above Their Intrinsic Value Estimate
Dec 06Is Health Catalyst (NASDAQ:HCAT) Using Debt In A Risky Way?
Nov 03Health Catalyst: Looking For A Turnaround For This 'Bio Boom' Candidate
Oct 14Health Catalyst names Kevin Freeman as Chief Growth Officer, Tarah Bryan as Chief Marketing Officer, Dave Ross as Chief Technology Officer
Sep 07Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$79m |
| Jun 30 2024 | n/a | n/a | -US$86m |
| Mar 31 2024 | n/a | n/a | -US$106m |
| Dec 31 2023 | n/a | n/a | -US$118m |
| Sep 30 2023 | n/a | n/a | -US$124m |
| Jun 30 2023 | n/a | n/a | -US$147m |
| Mar 31 2023 | n/a | n/a | -US$148m |
| Dec 31 2022 | US$4m | US$150k | -US$137m |
| Sep 30 2022 | n/a | n/a | -US$151m |
| Jun 30 2022 | n/a | n/a | -US$145m |
| Mar 31 2022 | n/a | n/a | -US$147m |
| Dec 31 2021 | US$6m | US$300k | -US$153m |
| Sep 30 2021 | n/a | n/a | -US$147m |
| Jun 30 2021 | n/a | n/a | -US$135m |
| Mar 31 2021 | n/a | n/a | -US$126m |
| Dec 31 2020 | US$5m | US$315k | -US$115m |
| Sep 30 2020 | n/a | n/a | -US$86m |
| Jun 30 2020 | n/a | n/a | -US$99m |
| Mar 31 2020 | n/a | n/a | -US$181m |
| Dec 31 2019 | US$4m | US$350k | -US$241m |
| Sep 30 2019 | n/a | n/a | -US$304m |
| Jun 30 2019 | n/a | n/a | -US$282m |
| Mar 31 2019 | n/a | n/a | -US$190m |
| Dec 31 2018 | US$5m | US$315k | -US$114m |
Compensación vs. Mercado: Datos insuficientes para determinar si la compensación total de Dan es razonable en comparación con empresas de tamaño similar en el mercado US.
Compensación vs. Ingresos: La compensación de Dan ha sido consistente con los resultados de la empresa en el último año.
CEO
Dan Burton (49 yo)
12.1yrs
Permanencia
Mr. Daniel D. Burton, also known as Dan, has been the Chief Executive Officer of Health Catalyst, Inc. since October 2012 and has been its Director since September 2011. Mr. Burton has strategy and leaders...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 12.1yrs | sin datos | 1.42% $ 6.5m | |
| Chief Financial Officer | less than a year | US$823.62k | 0.19% $ 860.4k | |
| General Counsel & Secretary of the Board | 1.5yrs | US$946.31k | 0.17% $ 761.0k | |
| Chief People Officer | 6.8yrs | US$1.06m | 0.029% $ 131.2k | |
| Chief Operating Officer | less than a year | sin datos | 0.051% $ 235.6k | |
| Chief Technology Officer | 2.2yrs | sin datos | sin datos | |
| Senior Vice President of Investor Relations and Financial Planning & Analysis | 3.8yrs | sin datos | sin datos | |
| Senior Vice President of Marketing & Communications | less than a year | sin datos | sin datos | |
| Chief Strategy Officer & Senior VP of Corporate Development | no data | sin datos | sin datos | |
| Senior Vice President of International | 5.5yrs | sin datos | sin datos | |
| Senior VP & Chief Clinical Officer | no data | sin datos | sin datos | |
| Chief Client Success Officer | no data | sin datos | sin datos |
2.2yrs
Permanencia media
46yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de HCAT se considera experimentado (2.2 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 13.2yrs | sin datos | 1.42% $ 6.5m | |
| Independent Chairman | 8.8yrs | US$316.16k | 0.18% $ 830.8k | |
| Independent Director | 4.8yrs | US$233.49k | 0.076% $ 349.7k | |
| Independent Director | 4.8yrs | US$237.25k | 0.073% $ 336.7k | |
| Independent Director | 8.6yrs | US$244.77k | 0.058% $ 267.7k | |
| Independent Director | 7.5yrs | US$244.77k | 0.092% $ 423.2k | |
| Independent Director | 1.3yrs | sin datos | sin datos |
7.5yrs
Permanencia media
60yo
Promedio de edad
Junta con experiencia: La junta directiva de HCAT se considera experimentada (7.5 años de antigüedad promedio).